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Abstract

Mirizzi Syndrome is a rare and challenging clinical entity to manage. However, recent advances in technology have provided surgeons
with new options for more effective diagnosis and treatment of this condition. This paper reviews these new diagnostic modalities and
treatment approaches for the management of Mirizzi Syndrome.
An online search language was performed using PubMed and Web of Science for literature published in English between 2012 and
2017 using the search terms “Mirizzi Syndrome” and “Mirizzi.” In total, 16 case series and 11 case reports were identiﬁed and
analyzed.
The most frequently used diagnostic modalities were ultrasound, computed tomography (CT); magnetic resonance
cholangiopancreaticography (MRCP); endoscopic retrograde cholangiopancreaticography (ERCP). A combination of ≥2 diagnostic
modalities was frequently used to detect Mirizzi Syndrome. Literature shows that the speciﬁc type of Mirizzi Syndrome determined
the type of treatment chosen. Open surgery was the preferred option, although there are documented cases of the use of minimallyinvasive techniques, even in advanced cases. Laparoscopic, endoscopic or robot-assisted surgery, used individually or in
combination with lithotripsy, were all associated with a favorable outcome.
As yet, there are no internationally-accepted guidelines for the management of Mirizzi Syndrome. Laparotomy is the preferred
surgical technique of choice, although an increasing number of surgeons are beginning to opt for minimally-invasive techniques. The
number of papers in the existing literature describing diagnostic and treatment procedures is relatively small at present, thus making it
difﬁcult to reasonably propose an evidence-based standard of care for Mirizzi Syndrome.
Abbreviations: ALT = alanine aminotransferase, AST = aspartate transaminase, CBD = common bile duct, CHD = common
hepatic duct, CT = computed tomography, EHL = electrohydraulic lithotripsy, ERCP = endoscopic retrograde cholangiopancreaticography, EUS = endoscopic ultrasound, LC = laparoscopic cholecystectomy, LL = laser lithotripsy, LSC = laparoscopic
subtotal cholecystectomy, MRCP = magnetic resonance cholangiopancreaticography, MS = Mirizzi Syndrome, NBD = nasal bile
drainage, PC or SC = partial (subtotal) cholecystectomy, RYHJ = Roux-en-Y hepaticojejunostomy, US = ultrasound.
Keywords: endoscopic, laparoscopic, Mirizzi Syndrome

In turn, the resulting chronic inﬂammation and ulceration
form varying degrees of cholecystobiliary ﬁstula. Furthermore,
cholecystoenteric ﬁstula may also occur.[4–7]
According to pathophysiological features, Mirizzi Syndrome
can be classiﬁed into several different types (Table 1). Mirizzi
Syndrome is detected in 0.06% to 5.7% of patients during
cholecystectomy, and in 1.07% of patients undergoing endoscopic retrograde cholangiopancreaticography (ERCP).[4,11,12]
Anatomical predispositions include side-by-side location of the
cystic and common hepatic ducts, coupled with a long, low
inserting cystic duct to the biliary tree. Beltrán[8] observed 9
anatomical elements associated with Mirizzi Syndrome. First, an
atrophic gallbladder with either thick or thin walls, with
impacted gallstones at the infundibulum or at the Hartmann’s
pouch, occasionally found ﬁrmly attached to the gallbladder
wall. Second, an obliterated cystic duct; which tends to represent
a common ﬁnding. Third, a long cystic duct running parallel to
the common bile duct with low insertion; this has been described
as a risk factor for Mirizzi Syndrome. Fourth, a normal but short
cystic duct. Fifth, partial obstruction by external compression of
the bile duct or by a gallstone eroding into the bile duct
originating from the gallbladder. Sixth, a normal caliber distal
bile duct with walls of normal thickness. Seventh, a dilated
proximal bile duct with thick inﬂamed walls. Eighth, an
anomalous communication between the gallbladder and the
bile duct. Finally, anomalous communication between the

1. Introduction
Kehr[1] and Ruge[2] were the ﬁrst to describe this condition in the
early 1900s, although the term “Mirizzi Syndrome” was not
adopted until after the work of Mirizzi[3] in 1948. This syndrome
is an uncommon complication of chronic gallstone disease.
Pathophysiologically, this condition involves extrinsic compression of the bile duct by pressure applied upon it indirectly by an
impacted stone in the infundibulum or neck of the gallbladder.
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criteria, we ultimately identiﬁed 27 papers for analysis, which
were published between 2012 and 2017. For each paper, we read
through the entire text and recorded the incidence and types
of MS, and the rates of preoperative diagnosis, diagnosis or
treatment modalities (Tables 2 and 3).
In most articles, ultrasound (US) was used as a preliminary
routine investigation although this technique was associated with
low diagnostic accuracy. According to the papers which provided
speciﬁc data, the most favorable diagnosis tool was ERCP (31.3–
100%), although percutaneous trans-hepatic cholangiography
was used as an option in cases where ERCP failed. The secondary
favorite modality was magnetic resonance cholangiopancreatography (MRCP), which was used in 7.1% to 80% of cases. The
literature also showed that computed tomography (CT) was
often performed to exclude tumors. However, most authors
preferred to use ≥2 modalities in combination. Diagnosis of
Mirizzi Syndrome prior to surgery occurred in 18% to 62% of
patients,[39] increasing to 85.9%[21] when MRCP and ERCP were
used in combination.
Surgery remains the preferred approach for the treatment of
Mirizzi Syndrome. Laparoscopic cholecystectomy (LC), which
has been used since 1987,[40] was ﬁrst reported to successfully
treat Type 1 Mirizzi Syndrome by Paul et al.[41] However, most
surgeons do not recommend LC as a viable standard of treatment
due to the increased risk of bile duct injury and a high conversion
rate with this condition. In the papers we reviewed, open surgery
was still the favorite treatment modality, accounting for 40% to
100% of cases. One systematic review, by Antoniou et al,[11]
associated laparoscopic treatment for Mirizzi Syndrome with low
success rates; consequently, these authors did not recommend this
technique. Despite these setbacks, minimally-invasive techniques
in the management of Mirizzi Syndrome continue to be explored,
albeit with limited application. Some treatment modalities, such
as endoscopic and robotic-assisted techniques, are beginning to
show preference with some authors.

Table 1
Combination of all classiﬁcations of Mirizzi Syndrome mentioned
in the literature[4–10].
Type I
external compression on CBD
Ia
the CBD go side by side with a long cystic duct
Ib
short cystic duct
Type II
presence cholecystobiliary ﬁstula and the diameter <1/3 of CBD
Or Mirizzi IIa
cholecystobiliary ﬁstula circumference <50% of the CBD
Mirizzi IIb
cholecystobiliary ﬁstula circumference >50% of the CBD
Type III
cholecystobiliary ﬁstula and the diameter up to 2/3 of CBD
Or Mirizzi III
presence cholecystobiliary and cholecystoenteric ﬁstula
Mirizzi IIIa
without gallstone ileus
Mirizzi IIIb
with gallstone ileus
Type IV
complete destruction of the CBD wall
Type V
formation of cholecystoenteric ﬁstula
Va
without gallstone ileus
Vb
with gallstone ileus
CBD = common bile duct.

gallbladder and the stomach, duodenum, colon, or other
abdominal viscera. Post-cholecystectomy residual cystic duct
stones have also been implicated in Mirizzi Syndrome.[13,14]
The clinical presentation of Mirizzi Syndrome ranges from
asymptomatic to non-speciﬁc, with obstructive jaundice (27.8–
100%) being the most common, elevated liver enzymes (AST/
ALT), right upper quadrant abdominal pain (16.7–100%), and
constitutional symptoms such as fever, nausea, vomiting,
diarrhea, and constipation. Although rare, Mirizzi Syndrome
may also present with gallstone ileus.[11] The nature of these
presentations often leads to this condition being confused with
biliary tract neoplasm[15] and misdiagnosis is therefore common.
The purpose of this article was to review existing literature
relating to the diagnosis and treatment of Mirizzi Syndrome
published within the last 5 years and to discuss the feasibility of
new approaches in the management of Mirizzi Syndrome.

2. Methods

4. Discussion

2.1. Search strategy and study selection

4.1. Classiﬁcation of Mirizzi Syndrome

PubMed and Web of Science were used to search the existing
literature for relevant articles published between 2012 and 2017.
The search used the search terms “Mirizzi Syndrome” and
“Mirizzi” and was limited to publications written in English. The
articles of any papers identiﬁed by the search were then screened
to assess whether the abstract described patients who had
undergone diagnosis and treatment for Mirizzi Syndrome using
any approach. Papers were excluded if they were not written in
English, if we could not obtain the full text, if there was no
mention of either diagnostic or treatment modalities in the text,
or if the publication was a review or a letter to the editor.
Ultimately, we identiﬁed 16 case series and 11 case reports for
inclusion (Tables 2 and 3). All selected articles were examined
and analyzed. This analysis comes from data published in the
study and does not involve patients, so no ethical approval is
required.

McSherry et al[5] described 2 types of Mirizzi Syndrome (Types I
& II) based on ERCP ﬁndings of ﬁstula formation. Type I
includes evidence of gallstones impacting upon the Hartmann
pouch or cystic duct along with slight external compression on
the common bile duct (CBD). Cases of Type II show corrosion of
the calculus into the CBD, along with cholecystobiliary ﬁstula.
McSherry’s classiﬁcation of Type II was further redeﬁned by
Csendes et al[6] into 3 further types, based on the extent of erosion
in the CBD circumference. Erosion involving less than one-third
of the CBD circumference remained known as Type II, erosion
up-to two-thirds the circumference of CBD became known as
Type III, while Type IV involves complete destruction of the CBD
wall. In 2008, Beltran et al[4] described an additional classiﬁcation, Type V, as the presence of any of the ﬁrst 4 types plus
the formation of a cholecystoenteric ﬁstula. Type V is further
divided into Type Va (without gallstone ileus) and Type Vb (with
gallstone ileus).
However, other classiﬁcations also exist. Starling and
Matallana[7] divided Type I into 2 subtypes: Ia (long cystic duct)
and Ib (short cystic duct). In one study, Mirizzi Syndrome was
present in 4 patients with acute acalculus cholecystitis. Opinion is
divided as to whether these represent a separate class of the
condition, or should be recognized as Type I. However, Beltrán[8]

3. Results
Historically, Mirizzi Syndrome has also been a problematical
clinical condition to diagnose and treat. It is therefore very
important to develop a clearer understanding of the diagnosis and
treatment modalities used for MS, and to establish new standards
of clinical care for MS. According to our inclusion and exclusion
2
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Table 2
Review studies of case series, arranged according to the periods of study, and evaluating the established treatment by type of MS.
Treatment
Case
(%)

Types
(%)

Xie-qun et al[16] 1988–2011

27 (0.31%)

Kumar et al[17] 1989–2011

169 (2.1%)

Reverdito et al[18] 2001–2013

13 (0.35)

Tung et al[19] 2004–
2010
Li et al[20] 2004–
2012

5

I 12 (44.4)
II 9 (33.3)
III 6 (22.2)
I 33 (20)
II 91 (57)
III 27 (17)
IV 9 (6)
III 12 (92)
IV 1 (8)
I 1 (20)
II 4 (80)
TAG:I 16
II 5 III 6
RAG:I 19
II 6 III 2
I 117 (59.1)
II 49 (24.7)
III 26 (13.1)
IV 6 (3.1)
I 19 (54.2)
II 7 (20)
III 5 (14.2)
IV 4 (9.6)
I 5 (45.5)
II 3 (27.3)
III 1 (9.1)
IV 2 (18.2)
I 6 (30)
II 8 (40)
III 5 (25)
IV 1 (5)
I 15 (83.3)
II 2 (11.1)
IV 1 (5.6)

Author/Period

27
27

Preoperative
Diagnostic (%)
-

Type
I

Type
II

LC (3)
OC (6)
LC to OC+TT (3)
OC (3)
OSC (26)
CD (3)
RYHJ (1)
-

LC (3)
OC+TT (3)
LC to OC+TT (3)
LSC (1)
CCP (81)
CD (6)
RYHJ (3)
-

15 (55.6)

3 patients
2 patients
ENBD+LC+IC (16)

16 (59.3)

OC (19)

LC+EHL+choledochoscopy
RLC+EHL+choledochoscop
ENBD+LC+IBE (3)
ENBD+LC+IC+TT (2)
OC+IC+TT (6)

170 (85.9)

OC (82)
PC (12)
LC (23)

24 (68.5)

Type
II

Type
IV

OC+RYHJ (6)

-

CP (8)
CD (2)
RYHJ (17)

RYHJ (9)

OC+RYHJ (9)
CD (1)
-

OC+RYHJ+TT (3)
-

ENBD+LC+IC+RYHJ (6)

-

OC+RYHJ (2)

-

PC (31)
CCP (18)

CCP (26)

RYHJ (6)

LC (14)
OC (5)

LC (4)
OC+TT (3)

OC+RYHJ (5)

OC+RYHJ (4)

5 (45.5)

LSC (5)
LSC+NBD (1)

LSC+NBD (2)
LC to OC (1)

LSC+NBD+IC
OC+EED+TT

OC+NBD+RYHJ

12 (72)

LSC

LSC+TT

LSC+TT+BEA

OC+RYHJ

-

LC (8)
LSC (2)
OC (3)
LC to OC (2)
LC (4)
LC to OC (4)
OC (7)
OC+RYHJ (1)
-

LSC (2)

-

OC+RYHJ

LC to OC (9)
OC+TT (34)
OC+RYHJ+TT (1)

-

-

54 (32)

7 (53.8)
-

Cui et al[21] 2004–2010

198 (0.66)

Lledó et al[22] 2006–
2012

35 (2.8)

Piccinni et al[23] 2006–2011

11 (2.97)

Kamalesh et al[24] 2006–2013

20 (1.4)

Testini et al[25] 2006–2016

23 (2.5)

Kulkarni et al[26] 2008–2014

60 (1.2)

I 16 (26.7)
II 44 (73.3)

Yuan et al[27] 2009–2014
Bhandari et al[28] 2011–2014

49
40 MS
10 CDs

-

Chuang et al[29] 2011–2015

11

II 49 (100)
I4
II 17
III 10
II 3 (27.3)
III 5 (45.5)
IV 3 (27.3)

6 (54.5)

-

Fabien et al[30] 2012–2014

5

-

-

Lee et al[31] 2012–
2013

5

II 2 (40)
III 3 (60)
I 2 (40)
II 3 (60)

ENBD+LSC+ICC
5 MS: stone extraction by ERCP
12MS: SOC-guided LL 4MS: SC+ERCP+LL
15MS: cholangioscopy-guided LL
LISC+LTBDE (2)
LRSC+LCBDE (1)
LRSC+LTBDE (1)
LRSC+LTBDE (4)

-

LRSC+LTBDE (2)
LISC+LCBDE (1)

To ALL:with ICC, and EHL or LL use or not
ENBD or Stent+ASC (2)
ASC+TT (3)
-

-

To All: endoscopic stent insertion+RLSC+ Choledochoscopy

ASC = anterograde subtotal cholecystectomy, BEA = bilioenteric anastomosis, CCP = choledochoplasty, CD = choledocho-duodenostomy, CDs = cystic duct stone, EED = mobilization of the duodeno-pancreatic
bloc and end-to-end anastomosis, EHL = electrohydraulic lithotripsy, ENBD = endoscopic nasal bile drainage, IBE = intraoperative biliary endoscopy, ICC = intraoperative choledochoscopy, LCBDE = laparoscopic
common bile duct exploration, LISC = laparoscopic infundibulotomy subtotal cholecystectomy, LL = laser lithotripsy, LRSC = laparoscopic retrograde subtotal cholecystectomy, LSC = laparoscopic subtotal
cholecystectomy, LTBDE = laparoscopic transﬁstulous bile duct exploration, MS = Mirizzi Syndrome, OC = open cholecystectomy, PC = partial cholecystectomy, RAG = treated with laparotomy (routine approach
group), RLC = robotassisted laparoscopic cholecystectomy, RLSC = robotassisted laparoscopic subtotal cholecystectomy, RYJH = Roux-en-Y hepatico-jejunostomy, SC = subtotal cholecystectomy, SOC = singleoperator cholangioscopy, TAG = treated with a combination of ERCP, laparoscopy, and choledochoscopy (tripartite approach group), TBS = temporary biliary stenting, TT = T-tube.
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Table 3
Review studies of case reports, arranged according to the publication year of study, and evaluating the applied treatment and it’s
limitation.
Author

Publication year

Donatelli et al[32]
Lim et al[13]
Faridi et al[33]
Rayapudi et al[34]
Milone et al[9]
Lacerda et al[35]
Kim et al[36]
Odemis et al[37]
Yetişir et al[31]
Yetişir et al[38]
Jones et al[14]

2012
2013
2013
2013
2014
2014
2014
2015
2016
2016
2017

Diagnostic methods
ERCP/MRCP
US/ERCP/MRCP
US/CT/IOD
CT/EUS/ERCP
MRCP
US/MRCP/IOD
CT/MRCP/ERCP/IUS
ERCP
US/ERCP/IOD
US/CT/ERCP
MRCP/ERCP

MS types

Treatment applied

PCMS I (2), I (1)
PCMS I
II with CDF
I
AACMS I
IV
II
PCMS I
V
III
PCMS I

Double cannulation followed by sphincterotomy and large balloon dilatation of papilla
ENBD+Elective laparoscopic exploration
Excision of CDF+SC+CP
Intraoperative CBD exploration + elective cholecystectomy
LC
AC+RYCJ
ILL under POC by using ultraslim upper endoscope
cystic duct balloon dilation at junction of the CBD and cystic duct stump
LRCF+LSC+ Tri-Staple
LSC+TT
POC+EHL

AACMS = Mirizzi Syndrome in acute acalculous cholecystitis, AC = anterograde cholecystectomy, CBD = common bile duct, CDF = cholecystoduodenal ﬁstula, CP = choledochoplasty, EHL = electrohydraulic
lithotripsy, EUS = endoscopic ultrasound, ILL = intraductal laser lithotripsy, IOD = intraoperatively diagnosis, IUS = intraductal ultrasonography, LRCF = laparoscopic resection of cholecystocolic fstula, LSC =
laparoscopic subtotal cholecystectomy, MS = Mirizzi Syndrome, PCMS = post-cholecystometic Mirizz syndrome, POC = peroral cholangioscopy, POC = single-operator peroral cholangioscopy, RYCJ =
choledocojejunal anastosomosis in Roux-en-Y, SC = subtotal cholecystectomy, TT = T-tube.

scanning is valuable in distinguishing Mirizzi Syndrome from
neoplasia. For example, Fabien et al[30] reported 5 cases in whom
CT scan adequately diagnosed Mirizzi Syndrome, and concluded
that adequate diagnosis can be reached on the basis of clinical
symptoms and images on a CT scan.

suggested that a simpliﬁed classiﬁcation would be useful. In their
classiﬁcation, Mirizzi I corresponds to McSherry Mirizzi Type I
while Mirizzi IIa and IIb have a cholecystobiliary ﬁstula
circumference less than half, and more than half of the CBD,
respectively. Mirizzi Type III can have cholecystobiliary and
cholecystoenteric ﬁstula, thus Mirizzi IIIa without gallstone ileus
and Mirizzi IIIb with. For further information on these
classiﬁcations, refer to Table 1. For the purpose of this article,
we have adhered to the classiﬁcation proposed by Csendes.
Our literature survey further showed that Mirizzi type I (10.5–
51%)[4,21,26] and Mirizzi type II (57%) are the most commonly
reported classiﬁcations.[17] Other types of Mirizzi Syndrome are
relatively low in incidence.

4.5. MRCP

Safe and effective surgical therapy is facilitated by accurate
preoperative diagnosis. However, such diagnosis is often missed
preoperatively, although more advanced cases of disease are
easier to detect before surgery. In this article, we explore the
following diagnostic modalities, which are all currently in use,
including: abdominal ultrasonography; CT; MRCP, and ERCP.

At present, MRCP is the preferred diagnostic tool, and is a noninvasive imaging technique with a 50% diagnostic accuracy rate.
MRCP can delineate the typical characteristics of Mirizzi
Syndrome, such as a stone in the common hepatic duct
(CHD), extrinsic compression of the CHD, and dilatation of
the CHD with normal-sized CBD. MRCP conﬁrmation is
required when ultrasound examination detects a dilated bile
duct with evidence of obstructive jaundice or stone impaction in
the bile duct. Biliary and pancreatic ducts can also be assessed by
MRCP, which can create superior images of inﬂammation
around the gallbladder. Such inﬂammation is characteristic of
Mirizzi Syndrome, and can therefore be used to distinguish
biliary conditions including cancer.[43] However, MRCP is not
efﬁcient at localizing a cholecystocholedochol ﬁstula.[23]

4.3. Abdominal US

4.6. ERCP

US is used as a routine investigation for biliary disease. This
technique can reveal gallstones and cholecystitis and reveal
evidence of Mirizzi Syndrome such as an atrophic gallbladder
and ectatic common hepatic duct with a normal distal CBD, or
edematous gallbladder caused by acute cholecystitis.[21] Existing
literature conﬁrms a diagnostic accuracy of 29%, with a
sensitivity between 8.3% and 27%.[8,17,18,26] In one study
involving 198 patients, the sensitivity of ultrasound for Mirizzi
Syndrome was as high as 77.8%.[21]

Despite its invasiveness, ERCP is considered a gold standard
diagnostic tool for Mirizzi Syndrome with a mean sensitivity rate
of 76.2%.[11,27] Indeed, Xie-qun et al[16] reported a 100%
sensitivity rate for ERCP. This technique yields superior
visualization of the extra-hepatic bile ducts, and can clearly
show extrinsic compression by impacted gallstones in the CBD
with resulting proximal biliary dilatation. Furthermore, ERCP
can accurately determine the presence and location of ﬁstula and
biliary obstruction. Therapeutic decompression by papillotomy
and stent or nasal bile drainage (NBD) can be achieved during
ERCP.[16,20] Moreover, an endoscopic NBD tube placed during
ERCP allows the outcome of surgery to be assessed through
endoscopic NBD cholangiography, thus facilitating minimallyinvasive laparoscopic surgery for Mirizzi Syndrome.[20] However, ERCP can also be associated with devastating complications
and its application in patients suffering Mirizzi Syndrome should
be considered with signiﬁcant caution.[8]

4.2. Diagnosis of Mirizzi Syndrome

4.4. CT
Although no speciﬁc radiological features of Mirizzi Syndrome can
be recognized on CT imaging, this technique can be very effective in
detecting the cause and location of biliary obstruction.[8,16,19] CT is
also useful for differentiating hepatic portal or hepatic inﬁltration
of tumors.[42] In patients with cholecystobiliary ﬁstula, CT
4

Chen et al. Medicine (2018) 97:4

www.md-journal.com

4.7. Other modalities of diagnosis

laparoscopic technique which is associated with high conversion
rates (31–100%) and an increased incidence of bile duct injury.
However, laparotomy has the advantage of better visualization,
haptic feedback, and gallbladder calculus removal before
cholecystectomy despite its more invasive nature, high complication rate, and longer postoperative hospital stay.
Total cholecystectomy is feasible in cases of Mirizzi Syndrome
Type I which are not associated with cholecystobiliary ﬁstula.
When severe inﬂammation impedes the safe dissection of Calot
triangle, retrograde fundus-ﬁrst cholecystectomy or partial
(subtotal) cholecystectomy (PC or SC, respectively) can be
applied.[16,22] Occasionally, it is necessary to visualize the CBD to
manage other causes of obstructive jaundice. One earlier case
reported intraoperative bile duct injury which was managed by
Roux-en-Y hepaticojejunostomy (RYHJ).[26]
In some cases, T-tube insertion into the bile duct is necessary,
not only to decompress the bile duct, but also to shape the duct in
order to minimize the risk of bile leakage, especially when the
quality of tissue repair is doubtful. This technique can also be
used to dispose of retained stones during intervention radiology.
PC or SC leaves a cuff of gallbladder or cystic duct remaining
that can be used to repair the ﬁstula of CBD (choledochoplasty), a
technique applicable in Mirizzi Syndrome type II and selected
type III cases.[16,21–23,25,30] However, choledochol-enteric anastomosis is a preferred alternative to this method.
Some authors consider that it is safer to curve the fundus of the
gallbladder and extract its contents before applying PC or SC.
This procedure has also been used in laparoscopic cholecystectomy.

The combination of ≥2 diagnostic modalities has become
commonplace in the management of Mirizzi Syndrome.
However, this practice is not supported by strong evidence
and there is currently no consensus among experts in terms of the
added beneﬁt of this practice.[23]
Other, less traditional modalities of diagnosis are also reported
in the literature. For instance, percutaneous transhepatic
cholangiography offers a reasonable option for diagnosis and
the relief of obstructive symptoms preoperatively, especially
when endoscopic treatment fails.[34,44] Furthermore, intraductal
ultrasonography can expose defects in the ductal mucosa,
suggesting the presence of a cholecystocholedochol ﬁstula.[36,44,45] Endoscopic ultrasound (EUS) can also be performed
prior to ERCP to further evaluate the bile ducts and pancreas and
to determine the cause of biliary strictures. For example,
Rayapudi et al[34] reported one case of Mirizzi Syndrome Type
1 by EUS examination.
4.8. Intraoperative diagnosis
A large number of patients are only diagnosed with Mirizzi
Syndrome during surgery.[46] Surgery can reveal a range of signs
associated with Mirizzi Syndrome, such as an edematous or
atrophic gallbladder with distortion of Calot triangle, an
impacted gallstone in the infundibulum or the neck of the cystic
duct, thick ﬁbrosis around Calot triangle, and adhesions under
the liver space. Cholecystobiliary ﬁstula is strongly suspected if
the extraction of an impacted stone is followed by the leakage of
bile from the bile duct.[16] Further intraoperative cholangiography can then be used to ascertain the position and dimension of
the ﬁstula, detect stones in the duct, and verify the integrity of the
bile duct wall, as well as retrieve residual stones in the
postoperative setting. However, there is some concern that this
technique is challenging to perform and carries a signiﬁcant risk
for secondary injury to the bile duct due to the distorted anatomy
commonly encountered at Calot triangle.[8]

4.10.1. Preoperative biliary decompression. In order to avoid
postoperative complications, Le Roux et al[30] applied preoperative drainage with endoscopic stent, or a nasobiliary drain,
placement by ERCP to avoid the insertion of T-tubes or
abdominal drains. Preoperative biliary drainage facilitates the
intraoperative identiﬁcation of the main bile duct. For Type IV,
there is consensus that the best surgical technique is cholecystectomy and RYHJ. However, some authors support the view that
the presence of a ﬁstula with a diameter wider than two-thirds of
the CBD (Type III and Type IV) should warrant RYHJ.[16–18,22]
The safest approach to manage Mirizzi Syndrome Type V is
always laparotomy.

4.9. Treatment of Mirizzi Syndrome
Surgical management is the mainstay treatment for Mirizzi
Syndrome, although this is challenging for several reasons. First,
there is a low index of suspicion for this condition among
surgeons, largely owing to its rarity, as gallbladder surgery is
often performed in patients with relatively shorter histories of
illness, long before the onset of Mirizzi Syndrome.[27] Secondly,
preoperative diagnosis is often missed, thus impacting upon the
ability to treat this condition during surgery. Thirdly, distortion
of the anatomy by dense adhesions due to longstanding
inﬂammation and the advancement of cholecystobiliary or
cholecysto-enteric ﬁstula, increases the risk of bile duct injury
or massive hemorrhage during dissection of Calot triangle.
Furthermore, inﬂammation can cause cutaneous ﬁstula, secondary biliary cirrhosis, delayed onset biliary strictures, and even
death. Tables 2 and 3 present treatment choices according to the
different subtypes of Mirizzi Syndrome found during our
literature review.

4.11. Laparoscopic, endoscopic and robot-assisted
techniques
4.11.1. Laparoscopic technique. The minimally-invasive laparoscopic approach has many advantages, including a shorter
hospital stay and a reduced waste of resources. However, when
applied to Mirizzi Syndrome, conversion rates are disappointingly high. Among the studies we reviewed, the conversion rate
ranged from 11.1% to 80%. It is, therefore, reasonable for some
experts to recommend limiting the laparoscopic approach to
managing Type I only, as more severe inﬂammation and
anatomical distortion would increase the risk of bile duct injury.
In a series of 23 patients, attempts at LC for Mirizzi Syndrome
were successful in only 1 patient (Type II).[17] Thereafter, the
author preferred to use open surgery. Despite the risks and
associated technical difﬁculties, some experts continue to
recommend LC and laparoscopic subtotal cholecystectomy
(LSC) for type II, and even type III. When performed, LSC is
similar in detail to PC or SC in laparotomy. Kamalesh et al[24]
performed LSC and bilioenteric anastomosis with T-tube
placement for patients with type III. Rohatgi and Singh[47]

4.10. Open surgical approach
Traditionally, laparotomy has been considered as the technique
of choice for the management of Mirizzi Syndrome. This is
largely due to its relative safety when compared with the
5
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treatment, as more experts have made attempts to popularize
minimally-invasive treatment techniques. LSC is feasible for Type
I, but can be selectively applied to Type II and even Type III.
Endoscopy and robot-assisted surgery, with or without EHL or
LL, currently stand as the best auxiliary methods. Nevertheless,
procedures for the diagnosis or treatment of Mirizzi Syndrome,
whether old or new, are limited by small sample sizes and there is
a clear need to design and implement further studies which
investigate a larger number of cases, and therefore provide
evidence-based data with which to create a standard of
management for Mirizzi Syndrome.

described a step by step description of the laparoscopic procedure
that emphasizes the classical section of the gallbladder fundus,
identiﬁcation of the infundibulum and cystic duct ab intra the
gallbladder by taking out the impacted calculus, and further
stated that these procedures could help to materialize the subtotal
cholecystectomy. In such cases, intraoperative cholangiography
is mandatory. Recently, a case report by Yetişir et al[48] described
a case of Mirizzi Syndrome Type V in which LSC was performed,
along with resection of a cholecystocolic ﬁstula and application
of Tri-Staples.
4.11.2. Endoscopic techniques. These methods play an
important part in the management of Mirizzi Syndrome. Patients
with Mirizzi Syndrome Types I, II, and III undergo ERCP
preoperatively with sphincterotomy and NBD insertion, and then
with LSC. NBD is used intraoperatively to decompress the bile
duct, identify the CBD and to perform an intraoperative
cholangiography. In some cases, T-tube insertion is avoided by
NBD insertion. The successful use of this method for Type III was
described by Li et al,[20] who performed LC combined with
intraoperative choledochoscopy and Roux-en-Y reconstruction.
Sometimes it is necessary to use laser lithotripsy (LL),
electrohydraulic lithotripsy (EHL), mechanical lithotripsy, or
chemical dissolution of residual stone fragments. LL is the most
commonly used method for this. Yetışır et al[38] proposed singleoperator cholangioscopy-guided LL and conventional cholangioscopy-guided LL, which have a 100% success rate for retrieving
stones. However, it is absolutely critical for these methods that
the surgeons involved are highly proﬁcient in endoscopy.
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[38] Yetışır F, Şarer AE, Acar HZ, et al. Laparoscopic treatment of Type III
Mirizzi Syndrome by T-tube drainage. Case Rep Surg 2016;2016:
1030358.
[39] Erben Y, Benavente-Chenhalls LA, Donohue JM, et al. Diagnosis and
treatment of Mirizzi syndrome: 23-year Mayo Clinic experience. J Am
Coll Surg 2011;213:114–9.
[40] Cuschieri A, Dubois F, Mouiel J. The European experience with
laparoscopic cholecystectomy. Am J Surg 1991;161:385–7.
[41] Paul MG, Burris DG, McGuire AM, et al. Laparoscopic surgery in the
treatment of Mirizzi’s syndrome. J Laparoendosc Surg 1992;2:157–63.
[42] Cornud F, Grenier P, Belghiti J, et al. Mirizzi syndrome and biliobiliary
ﬁstulas: roentgenologic appearance. Gastrointest Radiol 1981;6:265–8.
[43] Kim PN, Outwater EK, Mitchell DG. Mirizzi syndrome: evaluation by
MRI imaging. Am J Gastroenterol 1999;94:2546–50.
[44] Moon JH, Cho YD, Cheon YK, et al. Wire-guided intraductal US in the
assessment of bile duct strictures with Mirizzi syndrome-like features at
ERCP. Gastrointest Endosc 2002;56:873–9.
[45] Wehrmann T, Riphaus A, Martchenko K, et al. Intraductal ultrasonography in the diagnosis of Mirizzi syndrome. Endoscopy 2006;38:717–22.
[46] Safoleas M, Stamatakos M, Safoleas P, et al. Mirizzi Syndrome: an
unexpected problem of cholelithiasis. Our experience with 27 cases. Int
Semin Surg Oncol 2008;5:12.
[47] Rohatgi A, Singh KK. Mirizzi syndrome: laparoscopic management by
subtotal cholecystectomy. Surg Endosc 2006;20:1477–81.
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